Delivery Order SPE2DB24D1021-SPE2DB25FFAXR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $1,839.98. This non-set-aside delivery order, issued on August 29, 2025, with completion targeted for September 2, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $13,026.80. This competitively awarded, firm fixed-price contract was executed on September 2, 2025, with an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under no set-aside...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,766.03 for Modafinil 100 mg tablets (30-count packages) with a firm fixed price structure and an ultimate completion date of September 16, 2025. This non-set-aside contract was competitively awarded and reflects AmerisourceBergen's ongoing role as a critical pharmaceutical supplier to federal medical procurement systems. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,755.52 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) with a firm fixed price arrangement. This non-set-aside, competitively awarded contract was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a child delivery order under AmerisourceBergen's larger contract vehicle. The product will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,951.31 for Modafinil 100 mg tablets (30-count) with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $6,825.48 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on September 11, 2025, with a completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The award is being fulfilled from the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,724.25 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on July 24, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count) under a firm fixed-price contract valued at $2,641.58. The award, issued on August 20, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a $3,712.75 delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of June 6, 2025. This non-set-aside contract employs firm fixed price terms and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreements with the agency. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,690.40 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAXRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,106.80 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) with an ultimate completion date of September 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at approximately $1 billion and extends through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As the prime contractor under the broader DLA Troop Support Medical IDC, AmerisourceBergen leverages its comprehensive pharmaceutical supply capabilities to deliver medications across multiple therapeutic domains to support Defense Health Agency operations, the U.S. Coast Guard, and other federal healthcare systems. The SPE2DX contract represents a cornerstone of the company's federal medical supply portfolio, enabling flexible and scalable delivery of both specialty medications and generic pharmaceuticals to meet military healthcare requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 9/19/25 |